Haemonetics Stock Performance
| HAE Stock | USD 59.46 1.77 3.07% |
The company retains a Market Volatility (i.e., Beta) of -0.53, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Haemonetics are expected to decrease at a much lower rate. During the bear market, Haemonetics is likely to outperform the market. At this point, Haemonetics has a negative expected return of -0.34%. Please make sure to check out Haemonetics' downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to decide if Haemonetics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 3.07 | Five Day Return (8.52) | Year To Date Return (25.66) | Ten Year Return 86.1 | All Time Return 901.43 |
Last Split Factor 2:1 | Last Split Date 2012-12-03 |
1 | Heres Why Haemonetics is a Strong Growth Stock | 12/19/2025 |
2 | Strong Results Lifted Haemonetics Corporation in Q4 | 01/23/2026 |
3 | Stryker Surpasses Q4 Earnings and Revenue Estimates | 01/29/2026 |
4 | Haemonetics Q3 2026 Earnings Preview | 02/04/2026 |
5 | Haemonetics Q3 Earnings and Revenues Beat Estimates | 02/05/2026 |
6 | HAE Q4 Deep Dive Plasma Momentum and Hospital Weakness Shape Mixed Results | 02/06/2026 |
7 | Haemonetics International Revenue Performance Explored | 02/10/2026 |
| Begin Period Cash Flow | 178.8 M | |
| Total Cashflows From Investing Activities | -161.9 M |
Haemonetics | Build AI portfolio with Haemonetics Stock |
Haemonetics Relative Risk vs. Return Landscape
If you would invest 7,391 in Haemonetics on November 13, 2025 and sell it today you would lose (1,445) from holding Haemonetics or give up 19.55% of portfolio value over 90 days. Haemonetics is generating negative expected returns assuming volatility of 2.1264% on return distribution over 90 days investment horizon. In other words, 19% of stocks are less volatile than Haemonetics, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Haemonetics Target Price Odds to finish over Current Price
The tendency of Haemonetics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 59.46 | 90 days | 59.46 | about 98.0 |
Based on a normal probability distribution, the odds of Haemonetics to move above the current price in 90 days from now is about 98.0 (This Haemonetics probability density function shows the probability of Haemonetics Stock to fall within a particular range of prices over 90 days) .
Haemonetics Price Density |
| Price |
Predictive Modules for Haemonetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Haemonetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Haemonetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Haemonetics is not an exception. The market had few large corrections towards the Haemonetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Haemonetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Haemonetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.36 | |
β | Beta against Dow Jones | -0.53 | |
σ | Overall volatility | 7.80 | |
Ir | Information ratio | 0.05 |
Haemonetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Haemonetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Haemonetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Haemonetics generated a negative expected return over the last 90 days | |
| Haemonetics has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Haemonetics International Revenue Performance Explored |
Haemonetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Haemonetics Stock often depends not only on the future outlook of the current and potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.7 M | |
| Cash And Short Term Investments | 306.8 M |
Haemonetics Fundamentals Growth
Haemonetics Stock prices reflect investors' perceptions of the future prospects and financial health of Haemonetics, and Haemonetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Haemonetics Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.0645 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 3.54 B | ||||
| Shares Outstanding | 46.47 M | ||||
| Price To Earning | 50.35 X | ||||
| Price To Book | 2.94 X | ||||
| Price To Sales | 2.05 X | ||||
| Revenue | 1.36 B | ||||
| Gross Profit | 793.78 M | ||||
| EBITDA | 355.99 M | ||||
| Net Income | 167.68 M | ||||
| Cash And Equivalents | 306.76 M | ||||
| Cash Per Share | 4.79 X | ||||
| Total Debt | 1.22 B | ||||
| Debt To Equity | 1.12 % | ||||
| Current Ratio | 2.73 X | ||||
| Book Value Per Share | 19.46 X | ||||
| Cash Flow From Operations | 181.72 M | ||||
| Earnings Per Share | 3.63 X | ||||
| Market Capitalization | 2.7 B | ||||
| Total Asset | 2.45 B | ||||
| Retained Earnings | 352.17 M | ||||
| Working Capital | 356.86 M | ||||
| Current Asset | 488.09 M | ||||
| Current Liabilities | 185.55 M | ||||
About Haemonetics Performance
By analyzing Haemonetics' fundamental ratios, stakeholders can gain valuable insights into Haemonetics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Haemonetics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Haemonetics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 193.89 | 120.10 | |
| Return On Tangible Assets | 0.10 | 0.08 | |
| Return On Capital Employed | 0.09 | 0.13 | |
| Return On Assets | 0.05 | 0.07 | |
| Return On Equity | 0.12 | 0.11 |
Things to note about Haemonetics performance evaluation
Checking the ongoing alerts about Haemonetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Haemonetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Haemonetics generated a negative expected return over the last 90 days | |
| Haemonetics has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Haemonetics International Revenue Performance Explored |
- Analyzing Haemonetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Haemonetics' stock is overvalued or undervalued compared to its peers.
- Examining Haemonetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Haemonetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Haemonetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Haemonetics' stock. These opinions can provide insight into Haemonetics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |